Syndax Pharmaceuticals, Inc
Syndax Pharmaceuticals is dedicated to developing innovative therapies for cancer patients, focusing on areas such as acute leukemias, chronic graft-versus-host disease, and other focus areas. They aim to improve patient outcomes through their pipeline of clinical studies and products.
Industries
Nr. of Employees
medium (51-250)
Syndax Pharmaceuticals, Inc
Products
Therapeutic candidates for hematologic malignancies
Investigational therapeutic agents in development targeting blood cancers and related disorders; portfolio includes multiple clinical-stage candidates.
Therapeutic candidates for hematologic malignancies
Investigational therapeutic agents in development targeting blood cancers and related disorders; portfolio includes multiple clinical-stage candidates.
Services
Clinical study conduct
Execution and management of multicenter clinical trials for investigational therapeutics in oncology.
Compassionate use / expanded access
Provision and administration of expanded access programs to supply investigational therapies outside of formal trials.
Patient resources and enrollment support
Patient-directed information and contact resources to support trial enrollment and program inquiries.
Clinical study conduct
Execution and management of multicenter clinical trials for investigational therapeutics in oncology.
Compassionate use / expanded access
Provision and administration of expanded access programs to supply investigational therapies outside of formal trials.
Patient resources and enrollment support
Patient-directed information and contact resources to support trial enrollment and program inquiries.
Expertise Areas
- Clinical trial management
- Expanded access / compassionate use programs
- Oncology drug development
- Hematologic malignancies (acute myeloid leukemia, KMT2A-rearranged, NPM1-mutant; chronic graft-versus-host disease)
Key Technologies
- Clinical trial implementation
- Expanded access program administration
- Oncology therapeutic development
- Preclinical-to-clinical pipeline management